Contact

Pergamum AB
Banvaktsvägen 12
SE-171 48 Solna
Sweden

Jonas Ekblom, PhD
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
+46 8 470 37 40

Pergamum completes patient recruitment to the Phase II clinical trial for prevention of post-surgical adhesions
February 10, 2012
SWEDEN, STOCKHOLM - February 10, 2012. Pergamum AB announced today that the last patient has been dosed in a randomized Phase II trial...
Read more >>

Pergamum initiates Phase II trial with DPK‐060 in outer ear infections
January 16, 2012
STOCKHOLM, SWEDEN – January 16, 2012. Pergamum AB today announced that the first patient has been dosed in a randomized Phase II study...
Read more >>

Pergamum featured in a Swedish magazine on leading edge technology for combating antibiotics resistance (Swedish)
November 16, 2011
Små, positivt laddade molekyler som dödar bakterier så snabbt att de inte hinner utveckla resistens. Det lilla utvecklingsbolaget Pergamum vid Karolinska Development har...
Read more >>